Health AI Central
Share:
Peer-Reviewed Publication
Pathology2026;58(4):489-491.June 1, 2026Letter

STAT6 mutational status and expression in primary mediastinal large B-cell lymphoma.

Siba El Hussein1, Giby V George2, Diana G Adlowitz3, Lily B Benedict4, Fatima Zahra Jelloul5, L Jeffrey Medeiros5, W Richard Burack3, Dennis P O'Malley6
1Department of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA. Electronic address: elhusseinsiba@gmail.com.
2Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
3Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
4Department of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA.
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
6NeoGenomics, Aliso Viejo, CA, USA.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.